Data as of Q4 2025 (Dec 31, 2025)

EMR

(EMR)

Financial Statements · SEC EDGAR XBRL

Revenue
$18.02B
+3.0%
Net Income
$2.29B
+16.5%
EPS
$4.04
+17.8%
Gross Margin
52.8%
FCF
$2.67B
-8.4%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Non-Operating Income/Expense
Net Income
EPS (Basic)
EPS (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$18.02B
$17.49B
$15.16B
$19.63B
$18.24B
$18.02B
$17.49B
$15.16B
$19.63B
$18.24B
$8.50B
$8.61B
$7.74B
$11.44B
$10.67B
$9.52B
$8.88B
$7.43B
$8.19B
$7.56B
$2.29B
$1.97B
$13.22B
$3.23B
$2.30B
$4.06
$3.44
$23.00
$5.44
$3.85
$4.04
$3.43
$22.88
$5.41
$3.82